期刊文献+

腺样囊性癌细胞系中肿瘤干细胞的生物学特性初探 被引量:6

Cancer stem cell:seeking its evidences in adenoid cystic carcinoma cell line
下载PDF
导出
摘要 目的:对腺样囊性癌细胞系ACC-2中不同表型的肿瘤细胞生物学特性进行分析和研究,为肿瘤干细胞学说提供实验依据。方法:采用单细胞体外培养法,了解腺样囊性癌细胞(ACC-2)的分裂、增殖特点;采用免疫组化方法,检测ACC-2细胞表面CD44和CD24表达的差异性;应用免疫磁珠技术,分离不同表型的ACC-2细胞后,以裸鼠成瘤试验了解不同表型ACC-2细胞的成瘤能力。采用SPSS10.0统计软件包对所得数据进行X^2检验。结果:体外单细胞培养的ACC-2,仅有4.5%可持续分裂、增殖。CD44-和CD44+/CD24+细胞在体外培养条件下均无长期存活能力。不同表型的ACC-2动物成瘤试验结果显示,CD44+/CD24-亚群的ACC-2细胞最低成瘤接种细胞数显著低于常规ACC-2细胞,CD44-和CD44+/CD24+细胞则均无成瘤能力。免疫组化染色证实,CD44+/CD24-肿瘤细胞具有分化为其他表型肿瘤细胞的能力。结论:细胞表面抗原为CD44+CD24-的肿瘤细胞仅占ACC-2肿瘤细胞的极少部分,这些细胞具有极强的增殖能力和分化为其他表型肿瘤细胞的能力。ACC-2肿瘤细胞的增殖和成瘤能力源于CD44+/ CD24-细胞亚群。未分离的ACC-2细胞与CD44+/CD24-ACC-2细胞在与细胞分化、凋亡、黏连、信号传导等有关的基因上存在差异。提示ACC-2中存在肿瘤干细胞,而CD44+/CD24-是ACC-2肿瘤干细胞必须兼备的表面标志。 PURPOSE: The present study is designed to seek the evidences of tumor stem cell and reveal its impact on tumorigenesis of ACC-2 cell line by analyzing the biologic characteristics of different sub-clones of adenoid cystic carcinoma cell line (ACC-2). METHODS: In vitro individual cell culture was employed to observe the proliferating character of ACC-2 cells. The expression of CD44 and CD24 of ACC-2 cells were investigated by inmmnohistochemical assay. Immunomagnetic isolation of different phenotypes of ACC-2 cells, followed by cell culture, was used to study the proliferating abilities of different clusters of the cell line. The hetero-transplanted tumor mold was established using BALB/C nude mice by subcutaneous injection of tumor cells. The tumorigenic properties of the different clusters were investigated in vivo. RESULTS: The result of in vitro individual cell culture revealed that only 4.49% of cultured ACC-2 cell underwent division, proliferation and cell cloning, which indicated preservation of the prolonged live ability. All CD44- and CD44 +/CD24 + cells were failed to be eternal alive in the condition of in vitro individual cell culture. According to the results of in vivo tumorigenic study, the minimal cell quantity to develop a subcutaneous transplanted tumor by CD44+/CD24-cells was less than that of non-isolated ACC-2 cells and CD44+ cells. The CD44-and CD44+/ CD24+ were failed to develope transplanted tumors. Immunohistochemical study proved CD44+/CD24- ACC-2 cell could differentiate into cells of other phenotypes. CONCLUSIONS: It was suggested that heterogeneity exists in ACC-2 cell lines. There are some ACC-2 cells which display the following properties:They consisted in a very small portion of all ACC-2 cells. They were possessed of remarkable proliferating ability, and represented the sole cluster that can establish cell clone and alive eternally. They borne special phenotypes, and CD44+/CD24- were necessary. During the proliferation and differentiation, the expressing fashion of CD44 and CD24 might be changed. The tumorigenic ability of CD44+/CD24- cells were stronger than CD44+ and non-isolated ACC-2 cells. Eliminating of this cluster from ACC-2 would actually deprive the tumorigenic ability of the cell line. Supported by National Natural Science Foundation of China (Grant No. 30271425).
出处 《中国口腔颌面外科杂志》 CAS 2006年第4期289-294,共6页 China Journal of Oral and Maxillofacial Surgery
基金 国家自然科学基金(30271425)
关键词 腺样囊性癌(ACC) 肿瘤干细胞 免疫磁珠 成瘤试验 Adenoid cystic carcinoma Tumor stem cell Immunomagnetic beads Tumorigenesis
  • 相关文献

参考文献13

  • 1[1]Selby P,Buick RN,Tannock I.A critical appraisal of the "human tumor stem-cell assay"[J].N Engl J Med,1983,308(3):129-134.
  • 2[2]Kondo S.Carcinogenesis in relation to the stem-cell-mutation hypothesis[J].Differentiation,1983,24(1):1-8.
  • 3[3]Sell S,Pierce GB.Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers[J].Lab Invest,1994,70(1):6-22.
  • 4[4]Bonnet D,Dick JE.Human acute myeloid leukemia is organized as hierarchy that originates from a primitive hematopoietic cell[J].Nature Med,1997,3:730-737.
  • 5[5]Al-Hajj M,Wicha MS,Benito-Hernandez A,et al.Prospective identification of tumorigenic breast cancer cells[J].Proc Natl Acad Sci USA,2003,100:3983-3988.
  • 6[6]Singh SK,Clarke ID,Terasaki M,et al.Identification of a cancer stem cell in human brain tumors[J].Cancer Res,2003,63:5821-5828.
  • 7[7]Tu SM,Lin SH,Logothetis CJ.Stem cell origin of metastasis and heterogeneity in solid tumours[J].Lancet Oncol,2002,3:508-513.
  • 8[8]Marhaba R,Zoller M.CD44 in cancer progression:adhesion,migration and growth regulation[J].J Mol Histol,2004,35(3):211-231.
  • 9[9]Freje JM,Lawrence JA,Hollingshead MG,et al.Identification of compound with preferential inhibitory activity against low-Nm23-expression human breast carcinoma and melanoma cell lines[J].Nature Med,1997,4(5):395-401.
  • 10[10]Fodstad O,Faye R,Hoifodt HL.Immunobeads-based detection and characterization of circulating tumor cells in melanoma patients[J].Recent Results Cancer Res,2001,158(3):40-50.

二级参考文献20

  • 1景纯,温玉明,王大章,王昌美.口腔颊、舌鳞癌癌周淋巴管形态学特征与颈淋巴结转移[J].华西口腔医学杂志,1995,13(2):130-134. 被引量:26
  • 2Bian J H,Mol Cell Biol,1997年,17卷,11期,6330页
  • 3Yonemura Y;Endo Y;FuJita H.Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer,1999.
  • 4Tsurusaki T;Kanda S;Sakai H.Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis,1999(1-2).
  • 5Akagi K;Ikeda Y;Miyazaki M.Vascular endothelial growth factor C(VEGF C)expression in human colorectal cancer tissues[J],2000(07).
  • 6Joukov V;Pajusola K;Kaipainen A.A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases[J],1996(02).
  • 7Kukk E;Lymbouasaki A;Taira S.VEGF-C receptor binging and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development,1996(12).
  • 8Sleeman JP.The lymph node as a bridgehead in the metastatic dissemination of tumors,2000.
  • 9Lee J;Gray A;Yuan J.Vascular endothelial growth factorrelated protein: a ligand and specific activator of the tyrosine kinase receptor Flt4[J],1996(5).
  • 10Nicosia RJ.What is the role of vascular endothelial growth factorrelated molecules in tumor angiogenesis[J],1998(01).

共引文献17

同被引文献87

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部